People

Mateu-Gelabert-276x303
Pedro Mateu-Gelabert, PhD
National Development and Research Institutes, Inc. - Principal Investigator
Education
PhD, Sociology, New York University
BA, Sociology, Universidad Complutense, Madrid
Research Interests
Epidemiology of drug use, HIV/HCV prevention, Prescription opioid misuse, Overdose, HIV in Latin America, Urban ethnography
BIO
Pedro Mateu-Gelabert, PhD, is a principal investigator at NDRI and a sociologist with over 20 years of research experience in New York City and internationally. His research spans the epidemiology of drug use, urban studies, crime, immigration, social networks, and HIV/Hepatitis C prevention. He has more than 50 peer-reviewed publications and has been guest lecturer in numerous national and international forums including University of Chicago, Columbia University, Beth Israel Medical Center, Colombian Ministry of Health, Rio de Janeiro Office of Public Safety, and Office of Human Rights in San José (Costa Rica). Dr. Mateu-Gelabert has collaborated with various interdisciplinary research teams, including the New York City Department of Health and Mental Hygiene (NYCDOHMH), Weill Cornell Medical College, and Beth Israel Medical Center. He has worked on international projects in multiple countries including Colombia (Emerging heroin markets leading to HIV epidemics among young injectors), Spain (HCV prevention among injection drug users) and Ukraine (HIV treatment access and care cascade for people who inject drugs, DP1 DA034989). Dr. Mateu-Gelabert is currently Principal Investigator of the ongoing research project titled HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids (NIDA R01DA035146).
Projects
Principal Investigator, Accessible Care Intervention for Engaging People Who Inject Illicit Drugs (PWID) in Hepatitis C Care. Active
Principal Investigator, HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids. Active
Principal Investigator, Staying Safe Intervention: Preventing HCV Among Youth Opioid Injectors. Active
Principal Investigator, Staying Safe: Training IDUs in Strategies to Avoid HIV and HCV Infection. Completed
Publications

Recent

Toro-Tobon D, Berbesi-Fernandez D, Mateu-Gelabert P, Segura-Cardona AM, Montoya-Velez LP (2018).
Prevalence of hepatitis C virus in young people who inject drugs in four Colombian cities: A cross-sectional study using respondent driven sampling
International Journal of Drug Policy, 60, 56-64. doi: 10.1016/j.drugpo.2018.07.002.

Guarino H, Mateu-Gelabert P, Teubl J, Goodbody E (2018).
Young adults’ opioid use trajectories: From nonmedical prescription opioid use to heroin, drug injection, drug treatment and overdose
Addictive Behaviors, 86, 118-123. doi: 10.1016/j.addbeh.2018.04.017.

Mateu-Gelabert P, Guarino H, Quinn K, Meylakhs P, Campos S, Meylakhs A, Berbesi D, Toro-Tobon D, Goodbody E, Ompad DC, Friedman SR (2018).
Young drug users: A vulnerable population and an underutilized resource in HIV/HCV prevention
Current HIV/AIDS Reports, 15 (4), 324-335. doi: 10.1007/s11904-018-0406-z.

Palamar JJ, Le A, Mateu-Gelabert P (2018).
Not just heroin: Extensive polysubstance use among US high school seniors who currently use heroin
Drug and Alcohol Dependence, 188, 377-384. doi: 10.1016/j.drugalcdep.2018.05.001.

Mateu-Gelabert P, Guarino H (2018).
The opioid epidemic and injection drug use: MIPIE and health harms related to the injection of prescription opioids
International Journal of Drug Policy, 57, 130-132. doi: 10.1016/j.drugpo.2018.03.019.

Dr. Mateu-Gelabert's Google Scholar Profile
Selected Press